-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] In order to reduce the burden of patients' medical expenses and stabilize the clinical needs of medical institutions, the Hebei Provincial Medical Insurance Bureau has comprehensively considered factors such as product characteristics, supply, and quality of medical consumables, and has screened and carried out 22 types of medical consumables.
.
The results of this centralized procurement were announced on August 4 and will be implemented from September
.
It is understood that a total of 22 types of medical consumables were involved in this centralized procurement, including analgesic pumps, bone cement, ultrasonic cutter heads,
etc.
These are mostly clinical consumables with large market volume
.
For example, analgesia pump, which is a drug infusion device, is widely used in painless childbirth, medical aesthetics, orthopedics, thoracotomy (cranial) and cancer radical surgery
.
In recent years, with the increase in the number of surgeries, the market space for analgesia pumps has gradually increased.
The industry predicts that if the number of surgeries reaches 100 million in 2024, and the penetration rate is calculated at 40%, there will be 40 million applications, with an average of 1.
5 per person.
It is estimated that the market space will reach about 3 billion yuan
.
With the implementation of the "three-child" policy and the promotion of painless childbirth, the industry expects that the pain relief market is expected to usher in new growth
.
The average decline of the selected varieties was 56.
5%, of which the highest decline reached 89.
4%
.
Many varieties have dropped significantly.
For example, the thoracic (abdominal) puncture device has dropped from an average of 589 yuan to an average of 62 yuan, a drop of 89.
4%; the band ligator has dropped from an average of 1,852 yuan to an average of 548 yuan, a drop of 70.
4%; 6032 yuan decreased to an average of 1901 yuan, a decrease of 68.
5%
.
It is foreseeable that with the implementation of the results of this collection, the burden of related exchange costs will be greatly reduced
.
In order to further promote the realization of the masses' "take care of the disease, spend less money, and run less errands" and effectively reduce the burden of medical expenses, Hebei Province has actively promoted the work of centralized procurement and medical insurance adjustment in recent years.
.
For example, on June 28 this year, Hebei Province issued a document specifying that it will carry out pilot work at the provincial level to include some medical service items and medical consumables in the scope of medical insurance payment.
50 medical service items and 242 types of medical consumables will be included in the scope of medical insurance payment.
Floating expenses will also be included in the scope of medical insurance payments
.
It is reported that most of the medical consumables with the limited price are high-value medical consumables, and the limited price ranges from 1,000 yuan to 50,000 yuan
.
From July 1st, Hebei Province has implemented the results of the centralized procurement of high-value medical consumables such as coronary guide catheters and guide wires
.
In this centralized collection, the average price of selected coronary guide catheters decreased by 51%, and the selected price of coronary guide wires decreased by an average of 53%
.
The result of the selection of this centralized procurement also means that Hebei Province will basically achieve full coverage of the centralized procurement of high-value medical consumables (coronary stents, coronary balloons, coronary guide catheters and guide wires) in the field of coronary interventional therapy.
, to further reduce the burden of drug costs for patients
.
In addition to Hebei Province, in recent years, more and more provinces and cities in China, including Jiangsu, Fujian, Zhejiang, etc.
, have expanded the scope of centralized procurement and included more categories in centralized procurement.
Among them, Jiangsu Province has taken the lead in developing coronary stents in the country since 2019.
Since the centralized procurement, the province's centralized procurement scope has included orthopaedics, general surgery, cardiology, neurosurgery and other fields with large consumption of consumables, a total of 18 categories, with an average drop of more than 54%, and the cumulative annual savings in procurement funds exceeds 38.
5% billion
.
The industry expects that the volume-based procurement work will continue to move towards a broader and deeper field, and a new round of volume-based procurement may be launched in the second half of the year
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
The results of this centralized procurement were announced on August 4 and will be implemented from September
.
It is understood that a total of 22 types of medical consumables were involved in this centralized procurement, including analgesic pumps, bone cement, ultrasonic cutter heads,
etc.
These are mostly clinical consumables with large market volume
.
For example, analgesia pump, which is a drug infusion device, is widely used in painless childbirth, medical aesthetics, orthopedics, thoracotomy (cranial) and cancer radical surgery
.
In recent years, with the increase in the number of surgeries, the market space for analgesia pumps has gradually increased.
The industry predicts that if the number of surgeries reaches 100 million in 2024, and the penetration rate is calculated at 40%, there will be 40 million applications, with an average of 1.
5 per person.
It is estimated that the market space will reach about 3 billion yuan
.
With the implementation of the "three-child" policy and the promotion of painless childbirth, the industry expects that the pain relief market is expected to usher in new growth
.
The average decline of the selected varieties was 56.
5%, of which the highest decline reached 89.
4%
.
Many varieties have dropped significantly.
For example, the thoracic (abdominal) puncture device has dropped from an average of 589 yuan to an average of 62 yuan, a drop of 89.
4%; the band ligator has dropped from an average of 1,852 yuan to an average of 548 yuan, a drop of 70.
4%; 6032 yuan decreased to an average of 1901 yuan, a decrease of 68.
5%
.
It is foreseeable that with the implementation of the results of this collection, the burden of related exchange costs will be greatly reduced
.
In order to further promote the realization of the masses' "take care of the disease, spend less money, and run less errands" and effectively reduce the burden of medical expenses, Hebei Province has actively promoted the work of centralized procurement and medical insurance adjustment in recent years.
.
For example, on June 28 this year, Hebei Province issued a document specifying that it will carry out pilot work at the provincial level to include some medical service items and medical consumables in the scope of medical insurance payment.
50 medical service items and 242 types of medical consumables will be included in the scope of medical insurance payment.
Floating expenses will also be included in the scope of medical insurance payments
.
It is reported that most of the medical consumables with the limited price are high-value medical consumables, and the limited price ranges from 1,000 yuan to 50,000 yuan
.
From July 1st, Hebei Province has implemented the results of the centralized procurement of high-value medical consumables such as coronary guide catheters and guide wires
.
In this centralized collection, the average price of selected coronary guide catheters decreased by 51%, and the selected price of coronary guide wires decreased by an average of 53%
.
The result of the selection of this centralized procurement also means that Hebei Province will basically achieve full coverage of the centralized procurement of high-value medical consumables (coronary stents, coronary balloons, coronary guide catheters and guide wires) in the field of coronary interventional therapy.
, to further reduce the burden of drug costs for patients
.
In addition to Hebei Province, in recent years, more and more provinces and cities in China, including Jiangsu, Fujian, Zhejiang, etc.
, have expanded the scope of centralized procurement and included more categories in centralized procurement.
Among them, Jiangsu Province has taken the lead in developing coronary stents in the country since 2019.
Since the centralized procurement, the province's centralized procurement scope has included orthopaedics, general surgery, cardiology, neurosurgery and other fields with large consumption of consumables, a total of 18 categories, with an average drop of more than 54%, and the cumulative annual savings in procurement funds exceeds 38.
5% billion
.
The industry expects that the volume-based procurement work will continue to move towards a broader and deeper field, and a new round of volume-based procurement may be launched in the second half of the year
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.